Skip to main content

stock

ZNTL · Zentalis Pharmaceuticals, Inc.

What Zentalis Pharmaceuticals, Inc. reports to the SEC, read from its filings.

Open in the app

Price

The live ZNTL price and today's change.

Sign in to see this

Chart

Thirty days of daily bars, with signal levels drawn on them.

Sign in to see this

Signals

The latest signal group Nakagai's scanner recorded on ZNTL.

Sign in to see this

Options positioning

Gamma exposure levels from the options market.

Sign in to see this

Technicals

Trend, momentum and volatility gauges per timeframe.

Sign in to see this

What it is

Industry
Pharmaceutical Preparations (SIC 2834)
Filer (SEC EDGAR)
EDGAR filing index
Shares outstanding
71,671,914 as of 2026-08-03 (XBRL frame CY2026Q2I)

Key stats

Valuation

P/E
Locked
P/S
Locked
P/B
Locked
Enterprise value
Locked
EV/EBIT
Locked
FCF yield
Locked

Margins

Gross
—
Operating
—
Net
—

Returns

ROE
-97.1%
ROA
-64.8%

Health

Current ratio
4.8x
Debt/equity
—

Deep value

NCAV
$109.59M
NCAV per share
$1.53
Price/NCAV
Locked
NNWC
-$46.90M
NNWC per share
-$0.65
Price/NNWC
Locked

Valuation and the price multiples are built on the live price. Trailing twelve months to 2026-06-30; balance sheet at 2026-06-30.

Sign in to see this

Debt is long-term debt and its current portion. Commercial paper and short-term borrowings are not counted.

Results

Period endRevenueGross profit (not reported by this company)Operating incomeNet incomeFiling
2026-06-30——Gross profit: unreported by this company.-$44.39M-$42.29M
10-Q filed 2026-08-06
2026-03-31——Gross profit: unreported by this company.-$37.85M-$35.35M
10-Q filed 2026-05-12
2025-12-31$0—Gross profit: unreported by this company.-$37.39M-$35.22M
DEF 14A filed 2026-04-30
Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter.
Assembled from more than one filing; the filing above is only the newest of them.
2025-09-30$0—Gross profit: unreported by this company.-$33.73M-$26.69M
10-Q filed 2025-11-10
2025-06-30$0—Gross profit: unreported by this company.-$36.06M-$26.87M
10-Q filed 2026-08-06
Assembled from more than one filing; the filing above is only the newest of them.
2025-03-31$0—Gross profit: unreported by this company.-$45.62M-$48.28M
10-Q filed 2026-05-12
Assembled from more than one filing; the filing above is only the newest of them.
2024-12-31$26.86M—Gross profit: unreported by this company.-$49.85M-$47.50M
DEF 14A filed 2026-04-30
Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter.
Assembled from more than one filing; the filing above is only the newest of them.
2024-09-30$0—Gross profit: unreported by this company.-$51.43M-$40.16M
10-Q filed 2025-11-10
Assets
$215.33M
Equity
$143.65M

Balance as of 2026-06-30.

Ten years

Fiscal year endRevenueOperating incomeNet incomeFree cash flow
2025-12-31$0-$152.81M-$137.06M-$125.25M
2024-12-31$67.42M-$191.19M-$165.87M-$171.08M
2023-12-31$0-$299.51M-$292.31M-$208.41M
2022-12-31$0-$227.29M-$236.81M-$166.30M
2021-12-31—-$216.54M-$158.72M-$160.20M
2020-12-31—-$118.79M-$117.84M-$87.58M
2019-12-31—-$46.84M-$45.66M-$39.49M

Company filings

2 offering filings in 12 months

events

  • Other event

    Other event
    Aug 148-K
  • Results, Regulation FD disclosure

    ResultsRegulation FD disclosure
    Aug 68-K
  • Shareholder vote results

    Shareholder vote results
    Jun 188-K
  • Executive or director change

    Executive or director change
    May 278-K
  • Regulation FD disclosure, Other event

    Regulation FD disclosureOther event
    May 218-K
  • Results, Regulation FD disclosure

    ResultsRegulation FD disclosure
    May 128-K

5% owners ()

Insiders, politicians and funds

Insider trades, last 90 days

  • WALTERS GROUP

    10% owner

    Buy$15,172,500

    Aug 19, 6:11 PM ET

All insider trades for ZNTL

Politician trades, last 90 days

No politician trades filed in the last 90 days.

Funds

None of the tracked funds held this at their last 13F.

News

Stories that named ZNTL, and the market events around them.

Sign in to see this

Board

The ZNTL board could not be loaded.

Retry the ZNTL board

nakagai

Signals on ZNTL come from a rule, not a model.

Nakagai’s scanner records a signal the moment a strategy’s rule matches on the bars. Members read those signals on their own desk, where an agent journals the tape and briefs them in plain English.

Members post on the ZNTL board

This page is not financial advice. Trade at your own judgment and risk. Read the terms that govern posting here.

Zentalis Pharmaceuticals, Inc. (ZNTL): SEC filings, financials and insider trades · Nakagai